What is your approach to treating relapsed subcutaneous panniculitis-like T-cell lymphoma?  

Does it differ from the treatment of other relapsed peripheral T-cell lymphomas?

Are there any clinical trials or case series focused on SPTCL?

Is there data to guide the choice between consolidative autologous vs allogeneic HCT for SPTCL in CR2?

Answer from: Medical Oncologist at Academic Institution